Close Menu
Brittany Bathgate

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    AJet Ramps Up European Expansion with 99 Destinations and €9 Launch Fares

    August 20, 2025

    AfricAI Initiative Kicks Off in Nigeria to Drive AI Innovation Across Africa

    August 18, 2025

    WHO Data Reveals Billions Struggle with Oral Health – Dr Wonder Clinic Responds

    August 15, 2025
    Facebook X (Twitter)
    Trending
    • AJet Ramps Up European Expansion with 99 Destinations and €9 Launch Fares
    • AfricAI Initiative Kicks Off in Nigeria to Drive AI Innovation Across Africa
    • WHO Data Reveals Billions Struggle with Oral Health – Dr Wonder Clinic Responds
    • Breaking the Disposable Habit: Ninja Vapes’ Innovative Approach
    • Your Updated List of the Best Kinds of Exhibition Games You Can Utilise
    • Finding Freedom: How Simplifying Travel Can Change Your Parenting Journey
    • James Dooley Named UK’s Top Lead Generation Specialist at 2025 Manchester Awards
    • Hankook Prepares for Electrifying Showdown at London’s 2025 E-Prix Finale
    Facebook X (Twitter)
    Brittany BathgateBrittany Bathgate
    Subscribe
    Thursday, August 28
    • NEWS
    • ENTERTAINMENT
    • FINANCE
    • HEALTH
    • LIFESTYLE
    • POLITICS
    • PROPERTY
    • TECHNOLOGY
    • TRAVEL
    • WORLD
    Brittany Bathgate
    Home » AuriGen Medical’s Zenith device used in first patient treatment
    AuriGen Medical celebrating a successful First in Human Zenith procedure with Auckland City Hospital LAA implant team.
    HEALTH

    AuriGen Medical’s Zenith device used in first patient treatment

    Brittany BathgateBy Brittany BathgateOctober 15, 2024No Comments
    Share
    Facebook Twitter LinkedIn Pinterest Email

    AuriGen Medical, a company specialising in left atrial appendage occlusion (LAAO) technology, has announced the successful treatment of its first patient using its innovative “Zenith” device. The procedure, part of a first-in-human clinical study, was conducted at Auckland City Hospital in New Zealand by Dr Matt O’Connor, a cardiologist and electrophysiologist.

    This breakthrough marks a significant step in the development of the Zenith device, which aims to simplify LAAO procedures for patients suffering from atrial fibrillation (AF). AF affects more than 60 million people worldwide and is a major contributor to stroke, with over 90% of stroke-causing clots forming in the left atrial appendage (LAA). For AF patients who cannot tolerate long-term anticoagulation therapy, closing the LAA is a critical means of reducing stroke risk.

    The Zenith device offers a less invasive solution for LAA closure, using a minimally invasive procedure that involves a small incision in the groin. Once inserted, the device is guided to the heart, where it seals the LAA, significantly lowering the risk of clot formation. The system is designed for precision, allowing physicians to adjust the device’s placement to suit the patient’s unique heart anatomy.

    Dr Matt O’Connor, who performed the procedure, praised the device’s performance. “I am very encouraged by how the Zenith device performed in this important first case,” he said. “The patient recovered exceptionally well and has been discharged home. Zenith’s independent anchors provide a distinct advantage, allowing for easy repositioning and optimisation without risking injury to the heart. Combined with real-time leak analysis during the procedure, this represents a major advance in LAAO technology for our AF patients at high stroke risk.”

    The Zenith device is unique in its ability to offer intra-procedural checks, enabling physicians to reposition the device if needed. This feature allows doctors to perform leak analyses and adjust the implant for a more secure fit, reducing the chance of complications. Another standout feature is the device’s self-closing covering, designed to promote heart tissue growth over the implant, supporting long-term closure of the LAA and aiding recovery.

    AuriGen Medical’s chairman, Pierre Chauvineau, described the success of the first procedure as a major milestone for the company. “This first-in-human procedure is a huge step forward for AuriGen Medical and for LAAO technology as a whole. As we move forward with clinical trials, we remain committed to improving outcomes for patients requiring LAAO and exploring additional applications for Zenith that could benefit a broader range of cardiac patients.”

    With the increasing global prevalence of atrial fibrillation and the associated risk of stroke, innovations such as the Zenith device are set to play a crucial role in reducing health complications for AF patients. AuriGen Medical’s continued focus on refining and advancing LAAO technology could significantly enhance the treatment options available for this condition, improving patient care and outcomes.

    The company is expected to continue its clinical trials, further assessing the safety and effectiveness of the Zenith device for wider use in the treatment of atrial fibrillation.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Brittany Bathgate
    • Website

    Related Posts

    WHO Data Reveals Billions Struggle with Oral Health – Dr Wonder Clinic Responds

    August 15, 2025

    Post-Christmas LDL Spike Linked to Higher Diabetes Risk

    January 11, 2025

    Healthy Habits – The Key to Good Condition Every Day

    December 4, 2024
    Leave A Reply Cancel Reply

    Top Posts

    AJet Ramps Up European Expansion with 99 Destinations and €9 Launch Fares

    August 20, 2025

    Ruth Davidson On Life’s Challenges: Overcoming Trauma, Depression, and Finding Peace

    August 25, 2024

    Alison Hammond Reveals Financial Struggles Despite TV Fame

    August 25, 2024

    Princess Kate Makes A Surprise Balmoral Appearance With Royal Family

    August 25, 2024
    Don't Miss
    BUSINESS

    AJet Ramps Up European Expansion with 99 Destinations and €9 Launch Fares

    By Brittany BathgateAugust 20, 2025

    AJet, Türkiye’s rapidly growing carrier, is accelerating its growth across Europe under the Turkish Airlines…

    AfricAI Initiative Kicks Off in Nigeria to Drive AI Innovation Across Africa

    August 18, 2025

    WHO Data Reveals Billions Struggle with Oral Health – Dr Wonder Clinic Responds

    August 15, 2025

    Breaking the Disposable Habit: Ninja Vapes’ Innovative Approach

    August 8, 2025

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    Stay informed with Brittany Bathgate – your source for reliable news and expert insights. Explore our site for the latest stories and updates.

    Email Us: info@brittanybathgate.co.uk
    Contact: +1-320-0123-451

    Facebook X (Twitter)
    Our Picks

    AJet Ramps Up European Expansion with 99 Destinations and €9 Launch Fares

    August 20, 2025

    AfricAI Initiative Kicks Off in Nigeria to Drive AI Innovation Across Africa

    August 18, 2025

    WHO Data Reveals Billions Struggle with Oral Health – Dr Wonder Clinic Responds

    August 15, 2025
    Most Popular

    AJet Ramps Up European Expansion with 99 Destinations and €9 Launch Fares

    August 20, 2025

    Ruth Davidson On Life’s Challenges: Overcoming Trauma, Depression, and Finding Peace

    August 25, 2024

    Alison Hammond Reveals Financial Struggles Despite TV Fame

    August 25, 2024
    © 2025 ThemeSphere. Designed by ThemeSphere.
    • About Us
    • Contact
    • Meet the Brittany Bathgate Team
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.